TDAC

Translational Development Acquisition Corp.

Investor Moves

Name	Value	Action	Change	Price	Last Price
Ken GriffinCitadel Advisors $-176.2K ExitQ2 2025 $176k -- $10.71

Insider Trades

Name	Value	Action	Price	Last Price
Hoffman Michael BDirector, Officer: Chairman And CEO $614k53.4k shares BuyMay 27, 2026 $11.50 $10.71

News

globenewswire.comProLogium, a Next Generation Solid-State Battery Developer with 10+ Years of Proven Commercialization, to List on the Nasdaq through a Merger with Translational Development Acquisition Corp.globenewswire.comMay 27

Trade TDAC

About Translational Development Acquisition Corp.

Translational Development Acquisition Corp., founded in 2022 and headquartered in New York, New York, currently conducts no significant business operations. Its primary goal is to complete a business combination, such as a merger, amalgamation, share exchange, asset acquisition, share purchase, or reorganization, with one or more companies.

CEO: Michael Hoffman
IPO Date: Feb 20, 2025

Market Data

Open: $10.74
High: $10.75
Low: $10.73
Volume: 3.9K
Avg Volume: 99.5K
52W High: $10.80
52W Low: $10.27

Valuation

Market Cap: $235.5M
Enterprise Value: $236M
Dividend Yield: 0.00%

Financials

Free Cash Flow: -$608.4K
Revenue: $0
Net Income: $6.4M
Cash: $29.8K
Debt: $200K

Events

EarningsMay 15

actual 0.0608